On Aug. 10, 2018, Astellas Pharma announced that it has acquired Quethera, a Cambridge, United Kingdom-based gene therapy company focused on developing new treatments...

Business Secretary Greg Clark and Science Minister Sam Gyimah officially opened centre to ‘bridge the gap’ between scientific research and commercialisation of th...

Laetus, August 2018. High line speeds in production and packaging processes represent a major challenge to optical quality controls. The new SmartSpect Camera from La...

Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene ther...

Regeneron and Bluebird Bio have announced that they will collaboration to apply their respective technology platforms to the discovery, development and commercialisat...

A synthetic chemical (KHS101) has been discovered by researchers that has the ability to kill aggressive brain tumour cells by removing their source of energy. This ...

Regulatory T cells, or Tregs, ensure our immune responses don’t spin out of control and can cause autoimmune diseases. But on the flip side, they can also limit the p...

The European Medicines Agency's necessary relocation to Amsterdam following the U.K.'s Brexit vote has moved into its next phase with a business continuity plan "aime...